1. Home
  2. LKFN vs ADPT Comparison

LKFN vs ADPT Comparison

Compare LKFN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LKFN
  • ADPT
  • Stock Information
  • Founded
  • LKFN 1872
  • ADPT 2009
  • Country
  • LKFN United States
  • ADPT United States
  • Employees
  • LKFN N/A
  • ADPT N/A
  • Industry
  • LKFN Major Banks
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LKFN Finance
  • ADPT Health Care
  • Exchange
  • LKFN Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • LKFN 1.7B
  • ADPT 2.0B
  • IPO Year
  • LKFN 1997
  • ADPT 2019
  • Fundamental
  • Price
  • LKFN $59.73
  • ADPT $16.29
  • Analyst Decision
  • LKFN Buy
  • ADPT Strong Buy
  • Analyst Count
  • LKFN 2
  • ADPT 10
  • Target Price
  • LKFN $68.00
  • ADPT $14.10
  • AVG Volume (30 Days)
  • LKFN 94.6K
  • ADPT 1.9M
  • Earning Date
  • LKFN 10-27-2025
  • ADPT 11-05-2025
  • Dividend Yield
  • LKFN 3.34%
  • ADPT N/A
  • EPS Growth
  • LKFN N/A
  • ADPT N/A
  • EPS
  • LKFN 3.67
  • ADPT N/A
  • Revenue
  • LKFN $239,375,000.00
  • ADPT $205,216,000.00
  • Revenue This Year
  • LKFN $16.89
  • ADPT $32.63
  • Revenue Next Year
  • LKFN $4.98
  • ADPT $16.31
  • P/E Ratio
  • LKFN $16.31
  • ADPT N/A
  • Revenue Growth
  • LKFN N/A
  • ADPT 21.60
  • 52 Week Low
  • LKFN $50.00
  • ADPT $4.27
  • 52 Week High
  • LKFN $78.61
  • ADPT $17.62
  • Technical
  • Relative Strength Index (RSI)
  • LKFN 37.27
  • ADPT 65.83
  • Support Level
  • LKFN $61.07
  • ADPT $15.21
  • Resistance Level
  • LKFN $64.10
  • ADPT $17.62
  • Average True Range (ATR)
  • LKFN 1.91
  • ADPT 0.75
  • MACD
  • LKFN -0.42
  • ADPT 0.19
  • Stochastic Oscillator
  • LKFN 23.47
  • ADPT 68.44

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: